Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-12-01

FDA Approved: TAMOXIFEN CITRATE — Supplemental Application (Mayne Pharma Commercial LLC)

View source ↗

Summary

The FDA approved a supplemental application for tamoxifen citrate from Mayne Pharma Commercial LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamoxifen citrate (tamoxifen citrate)

Snippet

SUPPL AP for TAMOXIFEN CITRATE (TAMOXIFEN CITRATE)